See also this year's filing and all EDGAR filings for this company.
PDF Report 0001355250_2023_Innovation_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001355250, Innovation Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,952,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 6,427,000 |
| 4 | LiabilitiesCurrent | 4,808,000 |
| 5 | LiabilitiesNoncurrent | 841,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,216,184 |
| 9 | ResearchAndDevelopmentExpense | 5,347,220 |
| 10 | remainder_Expenses | 1,477,552 |
| 11 | remainder_Revenues | 18,000 |
| 12 | remainder_NetIncome | -93,205 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 10,379,000 |
| 1 | Liabilities | 5,649,000 |
| 2 | Expenses | 8,040,956 |
| 3 | Revenues | 18,000 |
| 4 | StockholdersEquity | 4,730,000 |
| 5 | NetIncome | -8,116,161 |
| 6 | ComprehensiveNetIncome | -8,116,161 |
| 7 | BaseVar | 12,090,080 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.274 |
| 9 | EconomicCapitalRatio | 1.68 |
Edgar->Model Mapping
Feature Distribution
Change over Time
